Dinoprostone

CAS Number: 363-24-6

Molecular Formula: C20H32O5

Purity: Dinoprostone 98% purity

About Dinoprostone

Prostaglandin E2 (CAS 363-24-6) serves as a cornerstone in the American obstetric landscape, where high purity fine chemicals with a Pharma/API purity of 99% are increasingly demanded by hospital systems adopting standardized labor induction protocols to manage rising post-term pregnancy rates. Dinoprostone is experien...

Dinoprostone Specifications

CAS Number

363-24-6

Molecular Formula

C20H32O5

Molecular Weight

352.47 g/mol

IUPAC Name

(5Z,11α,13E,15S)-7-[3-hydroxy-2-(3-hydroxyoct-1-enyl)-5-oxocyclopentyl]hept-5-enoic acid

Canonical SMILES

CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C/CCCC(=O)O)O)O

PubChem CID

5280360

HSN No

29375000

CAS Number

363-24-6

Molecular Formula

C20H32O5

Molecular Weight

352.47 g/mol

IUPAC Name

(5Z,11α,13E,15S)-7-[3-hydroxy-2-(3-hydroxyoct-1-enyl)-5-oxocyclopentyl]hept-5-enoic acid

Canonical SMILES

CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C/CCCC(=O)O)O)O

PubChem CID

5280360

HSN No

29375000

Molecular Weight

352.47 g/mol

Purity

Dinoprostone 98% purity

Labor Induction and Cervical Ripening Agent

A synthetic prostaglandin E2 (PGE2) used in obstetric care to stimulate uterine contractions and promote cervical softening, thinning, and dilation (cervical ripening) for the induction of labor at or near term

Abortifacient and Uterine Evacuant

A potent oxytocic agent indicated for the termination of pregnancy between the 12th and 20th gestational weeks and the evacuation of uterine contents in cases of missed abortion, intrauterine fetal death up to 28 weeks, or benign hydatidiform mole

Pharmaceutical Active Ingredient (API)

A high-purity crystalline powder used as a vital raw material for the formulation of vaginal inserts, gels, and suppositories in industrial pharmaceutical manufacturing

Biochemical Research Tool

A naturally occurring biomolecule and primary prostaglandin utilized in laboratory research to study prostaglandin E2 receptor activation, inflammatory pathways, and smooth muscle stimulation.